Archive: 29/10/2020
Validation of ERCC1/2 signature as radiosensitivity biomarker for tumor and normal tissues in NSCLC
A genetic analysis of non-small cell lung cancer (NSCLC) patients on the phase III NRG Oncology RTOG 0617 clinical trial assessing radiation dose discovered that high dose radiation therapy is associated with shorter survival ...
Oct 29, 2020